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Abstract
Background: Adenoid cystic carcinoma is a rare malignant parotid tumor. Metastasis can occur
even a decade or more after initial treatment of the primary.
Case presentation: We report a 60 year old female patient who presented with adenoid cystic
carcinoma of the parotid gland. She underwent a total conservative parotidectomy followed by
adjuvant radiotherapy. While on follow up, patient developed multiple liver metastases which
manifested three years later. Patient lived for another two years before she died of her disease.
Conclusions:  Although distant metastases of adenoid cystic carcinoma develop frequently,
isolated metastasis to liver is unusual. Even after manifestation of distant metastasis, patients can
be expected to live for a number of years. Palliative chemotherapy can be considered in
symptomatic cases while the usefulness of metastatectomy is controversial.
Background
Adenoid cystic carcinoma (ACC) is a rare malignant neo-
plasm of the salivary gland. Salivary gland neoplasms con-
stitute 3% of cancers of all sites, of which, 10–15% are
malignant [1,2]. Though ACC is the most common malig-
nant tumor of the submandibular, sublingual and minor
salivary glands, it accounts for only 15% of parotid can-
cers [3]. They are generally slow growing and spread
relentlessly to adjacent structures. Hematogenous spread
is more common than lymphatic spread, the common
sites of metastasis being the lung, bone and viscera [4,5].
We present a case of multiple liver metastases occurring 3
years after surgery for ACC of the parotid gland. The pri-
mary therapy, metastasis and outcome of ACC are
discussed.
Case presentation
A 60 year old woman presented with a small swelling
beneath the right ear lobe of 4 months duration. The
swelling measured 2 × 1 cm placed in the superficial part
of the parotid and was not fixed. There was no facial nerve
palsy or palpable cervical nodes. A fine needle aspiration
cytology (FNAC) was carried out which showed the lesion
to be ACC [6]. The clinical staging was T1, N0, M0. The
patient underwent a total conservative parotidectomy
after metastatic work up. Histopathology revealed ACC
with cribriform pattern and perineural invasion (Figure
1). 60 Gy adjuvant external beam radiotherapy was
administered post-operatively to the parotid area and the
neck. Patient was placed on regular follow-up. Three years
after primary surgery, patient presented with heaviness
and pain in the right hypochondrium of 15 days duration.
Patient was anicteric and abdominal examination
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revealed firm nodular and non tender enlargement of the
liver. There was no ascites. Surgical site and neck were
clinically normal. Chest roentgenogram was normal.
Ultrasonography (US) of the abdomen revealed multiple
metastatic lesions scattered in both lobes (Figure 2). Liver
function tests were normal and an US guided FNAC
revealed metastatic ACC (Figure 3). Since the lesions were
multiple and scattered over both lobes of liver, surgical
option was not considered and the patient was offered
palliative chemotherapy which she declined. She devel-
oped pedal edema and abdominal distention 20 months
after detection of liver metastasis. On clinical examina-
tion, patient was anicteric but liver had increased in size
and abdomen showed evidence of a little free fluid. Chest
CT scan was normal. Bone scan did not suggest any meta-
static focus. Patient died a month later still without evi-
dence of local recurrence or pulmonary metastasis.
Conclusions
Although ACC is the second most common malignant sal-
ivary gland neoplasm and constitutes approximately one
third of all salivary gland malignancies it constitutes only
2% of parotid neoplasms [3]. As ACC is neurotropic, fro-
zen section analysis of nerve margins is suggested spe-
cially when nerve is grossly involved by the tumor [7]. A
total conservative or a radical parotidectomy is advocated
for ACC though the main intent is to obtain a tumor free
area of at least 1 cm [8]. ACC, with its often unusually
slow biologic growth, tends to have a protracted course
and ultimately a poor outcome, with a 10-year survival
Photomicrograph showing small darkly stained cells with scanty cytoplasm arranged in nests fenestrated by round or oval  spaces – cribriform pattern, H & E (× 100) Figure 1
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reported to be less than 50% for all grades [9,10]. These
carcinomas typically show frequent recurrences and late
distant metastases [11]. In a retrospective review of 92
cases, a tumor size greater than 4 cm was associated with
an unfavorable clinical course [12]. Cribriform and solid
patterns seen histologically were thought to predict more
biological aggressiveness while tubular pattern repre-
sented more differentiated pattern of ACC. Over long peri-
ods of patient follow-up such grade based prognostication
is less valid. Currently, stage and tumor location are the
only factors considered prognostically significant [13].
Radiotherapy has been used as a primary modality for
patients with surgical contraindications and in those with
unresectable neoplasms. Though no improvement in sur-
vival is reported, the use of adjuvant radiation improves
locoregional control and disease free survival. This patient
received adjuvant radiation and did not have any locore-
gional recurrence.
Regional metastasis is less common occurring in about
17% while systemic failure occurs in 33 to 50% of the
patients [4,8]. Though involvement with distant metas-
tases are unpredictable, organs involved in the order of
decreasing frequency are lung, bone, brain and the liver
[3]. Other rare metastatic sites of parotid and non parotid
ACC include stomach, toe, choroids, brain and skin [14-
18]. The initial site of metastasis is usually the organ con-
taining the first capillary bed (first filter) and hence lungs
would be the common site of metastasis [19]. Clinical
observations from various malignancies have indicated
that metastasis from certain types of tumor tend to occur
in specific target organs leading to the famous 'soil and
seed' hypothesis where metastatic cells 'home' to the
Abdominal ultrasound showing multiple hypoechoiec (short arrow) and hyperechoeic lesions (long arrow) in the liver Figure 2
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organ [20]. Though liver metastasis has been reported,
most of the liver metastases reported are of non parotid
ACC [3,5]. The occurrence is usually metachronous or
synchronous with metastasis to other organs like the lung
as it is the first filter. In the series of Spiro, of the 74
patients developing metastasis from salivary gland ACC,
23 did so without loco-regional recurrence while 5 had
isolated bone metastasis [5]. Sung and colleagues found
metastases in 46 out of 94 head and neck ACC [21]. In
that study, only one patient developed liver metastasis
and that patient had metastasis to both lung and bone. In
this case, the patient manifested with multiple metastatic
foci in the liver as the first and only metastatic organ
which is very unusual. Surgical options of metastatectomy
were not explored as patient had multiple metastases
involving both lobes of liver. Although the patient lived
with disease for a further two years, she did not show any
evidence of lung metastasis or loco-regional recurrence. In
this patient, the liver metastasis could have occurred prior
to treatment as an organ of preference; evidenced by the
fact that there were no other organs showing metastasis
nor was there a loco-regional recurrence later. Studies in
ACC have shown long tumor doubling times of pulmo-
nary metastasis and late recurrences up to 10 years after
primary treatment [22]. The estimated doubling time of
lung metastasis in ACC ranges from 200 to 600 days [22].
There is even a suggestion that metastasis at the cellular
level could occur many years prior to clinical presentation
of primary tumor. FNAC was done to prove the metastatic
foci in this patient and can be a useful tool for diagnosis
[23]. Although this patient declined chemotherapy,
chemotherapeutic responses have been reported in ACC
[24]. ACC carries a mortality of 75–80% over a 30 year
period and most patients who die of their disease do so
FNAC liver showing metastatic ACC, H & E (× 400) Figure 3
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between 5 and 10 years after initial treatment [10]. Our
patient died 5 years from diagnosis with metastatic dis-
ease that developed 3 years after initial treatment.
ACC is a rare malignant tumor of parotid gland. Metasta-
sis can manifest very late and hence a long term follow-up
and a high index of suspicion is necessary to diagnose
them early. An annual ultrasound study of abdomen
would be desirable on follow-up. Unlike metastasis from
other malignancies, these grow indolently and long term
survival can be expected even with multiple metastases as
also evidenced in the present case. Chemotherapy could
be considered in selected patients as a therapeutic option
in metastatic disease.
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